19-36005343-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001039876.3(SYNE4):c.962G>A(p.Arg321Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,614,006 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R321W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001039876.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SYNE4 | NM_001039876.3 | c.962G>A | p.Arg321Gln | missense_variant | 6/8 | ENST00000324444.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SYNE4 | ENST00000324444.9 | c.962G>A | p.Arg321Gln | missense_variant | 6/8 | 5 | NM_001039876.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152074Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000341 AC: 85AN: 249534Hom.: 2 AF XY: 0.000288 AC XY: 39AN XY: 135386
GnomAD4 exome AF: 0.000241 AC: 352AN: 1461814Hom.: 6 Cov.: 31 AF XY: 0.000191 AC XY: 139AN XY: 727206
GnomAD4 genome AF: 0.000217 AC: 33AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74402
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 09, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 321 of the SYNE4 protein (p.Arg321Gln). This variant is present in population databases (rs150043310, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with SYNE4-related conditions. ClinVar contains an entry for this variant (Variation ID: 504862). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 13, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 04, 2019 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 12, 2017 | p.Arg321Gln in exon 6 of SYNE4: This variant is not expected to have clinical si gnificance due to a lack of conservation across species, including mammals. Of n ote, >10 mammals have a Gln at this position. In addition, computational predict ion tools do not suggest a high likelihood of impact to the protein. This varian t has also been identified in 0.11% (21/18870) of East Asian chromosomes includi ng 2 by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.or g; dbSNP rs150043310). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at